Author

E. Fourgous

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

S. Roche· 3 shared M. Pons· 2 shared P. P. Fort· 2 shared Y. Boublik· 2 shared A. Fernandez· 1 shared A. Sirvent· 1 shared A.-L. Le Roux· 1 shared c. recher· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

S. Roche

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Lipid-mediated dimerization of membrane-anchored c-Src is driven by a cluster of lysine residues in the N-terminal SH4 domain.

I.-L. Mohammad, J. Carvajal, A. Fernandez, M. Taules, E. Fourgous, Y. Boublik, A.-L. Le Roux, S. Roche, M. Pons

This study identifies a cluster of lysine residues in the SH4 domain of c-Src that enhances lipid-mediated dimerization, increasing tyrosine phosphorylation in HEK293T cells.

bioRxiv · May 31, 2022 · PreprintBiophysics

SHED-dependent oncogenic signalling of the PEAK3 pseudo-kinase

y. OUNOUGHENE, E. fourgous, Y. Boublik, E. Saland, N. Guiraud, c. recher, s. urbach, P. P. Fort, J.-E. Sarry, d. fesquet, s. roche

This study identifies PEAK3 as an oncogenic pseudo-kinase that uses the SHED module to activate AKT signaling and promote cancer growth.

bioRxiv · Aug 30, 2021 · PreprintCancer Biology

Regulation of Src tumor activity by its N-terminal intrinsically disordered region

E. APONTE, M. Lafitte, A. Sirvent, V. Simon, M. barbery, E. Fourgous, M. Maffei, F. Armand, R. Hamelin, J. Pannequin, P. P. Fort, M. Pons, s. roche

This study identifies the ULBR in Src as essential for its oncogenic activity by modulating membrane substrate phosphorylation.

bioRxiv · May 10, 2021Cancer Biology